Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

362.28 5.51 −1.50%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
25.11 23.01 23.49 23.80

+8 more quarters

P/S ratio
1.71 1.59 1.55 1.50
P/FCF ratio
21.60 22.16 17.41 19.40
P/Operating CF
44.32 51.35 114.67 33.98
P/B ratio
2.82 2.66 2.52 2.42
EV/Sales
2.06 2.00 1.90 1.83
EV/EBITDA
13.61 13.07 12.63 12.34
EV/FCF
25.97 27.76 21.31 23.69
Current Ratio
1.41 1.80 1.73 1.42
Net Debt/EBITDA
6.92 9.16 8.87 15.83
Debt/Equity
0.60 0.69 0.68 0.60
Earnings Yield
3.98% 4.35% 4.26% 4.20%
Free Cash Flow Yield
4.63% 4.51% 5.74% 5.15%
Free Cash Flow per Share
4.96 3.87 0.95 5.99
Book value per Share
109.10 105.35 106.06 103.60
Free Cash Flow
402.50 315.80 78.30 498.30
EV/EBIT
20.00 19.15 18.67 18.41
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026